Clinical Characteristics of Chronic Daily Headache Patients Visit to University Hospital

Similar documents
Risk Factors for Chronic Daily Headache

Frequent headaches (FH) occur 15 or more

Chronic migraine classification: current knowledge and future perspectives

Prevalence of new daily persistent headache in the general population. The Akershus study of chronic headachecha_

Psychiatric Comorbidity in Transformed Migraine: Presentation, Treatment, Impact and Outcome

Chronic Daily Headaches

Cluster headache in women: clinical characteristics and comparison with cluster headache in men

A new questionnaire for assessment of adverse events associated with triptans: methods of assessment influence the results. Preliminary results

Levetiracetam in the Preventive Treatment of Transformed Migraine: A Prospective, Open-Label, Pilot Study

From drug-induced headache to medication overuse headache. A short epidemiological review, with a focus on Latin American countries

Does repeated subcutaneous administration of sumatriptan produce an unfavorable evolution in cluster headache?

Psychiatric disorders in chronic daily headache: detection by means of the SCID interview

By Nathan Hall Associate Editor

23 How Cluster Headache and Other Trigeminal Autonomic Cephalalgias Present

Treatment of Intractable Hemicrania Continua by Occipital Nerve Stimulation

Does analgesic overuse matter? Response to OnabotulinumtoxinA in patients with chronic migraine with or without medication overuse

New daily persistent headache: Should migrainous features be incorporated?

Field testing of the ICHD-3β and expert opinion criteria for chronic migraine

Zonisamide for migraine prophylaxis in refractory patients

Chronic tension-type headache: Advice for the viselike-headache patient

6/2/2017. Objectives. Statement of Problem: Migraine Headaches Are Common. Chronic Headache In Pediatrics, Botox and Beyond

Trigeminal Autonomic Cephalalgias: Paroxysmal Hemicrania, SUNCT/SUNA, and Hemicrania Continua

Value of postmarketing surveillance studies in achieving a complete picture of antimigraine agents: using almotriptan as an example

New Daily Persistent Headache in Children and Adolescents

ORIGINAL INVESTIGATION. Headache Evaluation and Treatment by Primary Care Physicians in an Emergency Department in the Era of Triptans

Migraine Diagnosis and Treatment: Results From the American Migraine Study II

Fatigue in chronic migraine patients

Cluster headache and paroxysmal hemicrania: differential diagnosis

The Clinical Profile of Sumatriptan: Cluster Headache Key Words

David W. Dodick M.D. Professor Director of Headache Medicine Department of Neurology Mayo Clinic Phoenix Arizona USA

Trigeminal Autonomic Cephalalgias. Disclosures. Objectives 6/20/2018. Rashmi Halker Singh, MD FAHS UCNS Review Course June 2018

Hemicrania continua-like headache associated with carotid dissection may respond to indomethacin

Identification of negative predictors of pain-free response to triptans: Analysis of the eletriptan database

CLUS 42 PRACTICAL NEUROLOGY. Pract Neurol: first published as /j x on 1 October Downloaded from

Aleksandra Radojičić. Headache Center, Neurology Clinic, Clinical Center of Serbia

Update on Hemicrania Continua

Cluster headache (CH): epidemiology, classification and clinical picture

Medication overuse headache: a critical review of end points in recent follow-up studies

ORIGINAL CONTRIBUTION. Efficacy and Safety of Acetaminophen, Aspirin, and Caffeine in Alleviating Migraine Headache Pain

Prevalence of headache in an elderly population: attack frequency, disability, and use of medication

PREVALENCE BY HEADACHE TYPE

An Expert System for Headache Diagnosis: The Computerized Headache Assessment Tool (CHAT) Morris Maizels, MD; William J.

RISK FACTORS AND PROGNOSIS OF CHRONIC MIGRAINE

Treatment satisfaction with zolmitriptan nasal spray for migraine in a real life setting: results from phase two of the REALIZE study

Reviews/Evaluations. Medication-Overuse Headache

...SELECTED ABSTRACTS...

Zolmitriptan is effective and well tolerated in Japanese patients with migraine: a dose response study

Post-infectious headache: a reactive headache?

Case Presentation. Case Presentation. Case Presentation. Truths about Headaches (2017) Most headaches were muscle-tension headaches

Measure Components Numerator Statement

Zolmitriptan nasal spray provides fast relief of migraine symptoms and is preferred by patients: a Swedish study of preference in clinical practice

Disease Description and Statistics Current State: Medicare Denial of Coverage Expert Opinion Clinical Studies Gap in Medical Care Cost to US

MEASURE #4: Overuse of Barbiturate Containing Medications for Primary Headache Disorders Headache

Application of ICHD 2nd edition criteria for primary headaches with the aid of a computerised, structured medical record for the specialist

Nee Kong CHEW, Chong Tin TAN, Heng Thay CHONG, Yau Hoong CHAN, Kuoh Ren CHONG, Hee Hong LAM, Yan Beng NGE, Chek Tung NGO.

GENERAL APPROACH AND CLASSIFICATION OF HEADACHES

UTILIZATION MANAGEMENT CRITERIA

Nerve growth factor and chronic daily headache: a potential implication for therapy

A case of a patient with chronic headache. Focus on Migraine. None related to the presentation Grants to conduct clinical trials from: Speaker bureau:

Migraine Management. Roger Cady, MD Headache Care Center Springfield, MO

Topiramate intervention to prevent transformation of episodic migraine: The topiramate INTREPID study

11. HEADACHE 1. Pablo Lapuerta, MD, Steven Asch, MD, MPH, and Kenneth Clark, MD, MPH

What is the Effectiveness of OnabotulinumtoxinA (Botox ) in Reducing the Number of Chronic Migraines (CM) in Patients Years Old?

TREXIMET UTILIZATION MANAGEMENT CRITERIA

Comprehensive Application of the International Classification of Headache Disorders Third Edition, Beta Version

Prednisone vs. placebo in withdrawal therapy following medication overuse headache

IMITREX UTILIZATION MANAGEMENT CRITERIA

The Economic and Social Impact of Migraine Key Words

Tears of Pain SUNCT and SUNA A/PROFESSOR ARUN AGGARWAL RPAH PAIN MANAGEMENT CENTRE

Cluster headache in Greece: an observational clinical and demographic study of 302 patients

Atypical presentations of cluster headache

HEADACHE 1 Pablo Lapuerta, M.D., and Steven Asch, M.D., M.P.H.

An Overview of MOH. ALAN M. Rapoport, M.D. Clinical Professor of Neurology The David Geffen School of Medicine at UCLA Los Angeles, California

Inpatient Treatment of Status Migraine With Dihydroergotamine in Children and Adolescents

10/13/17. Christy M. Jackson, MD Director, Dalessio Headache Center Scripps Clinic, La Jolla Clinical Professor, Neurosciences UCSD

Topiramate plus nortriptyline in the preventive treatment of migraine: a controlled study for nonresponders

Migraine Migraine Age Specific Prevalence in the United States. Headache International Headache Society Classification

The global burden of migraine

TABLE 1. Current Diagnostic Criteria for Migraine Without Aura 2 A. At least 5 attacks fulfilling criteria B-D B. Headache attacks lasting 4-72 hours

The validity of questionnaire-based diagnoses: the third Nord-Trøndelag Health Study

The prevalence of premonitory symptoms in migraine: a questionnaire study in 461 patients

medications. This was an openlabel study consisting of patients with migraines who historically failed to respond to oral triptan

UNDERSTANDING CHRONIC MIGRAINE. Learn about diagnosis, management, and treatment options for this headache condition

Open Access RESEARCH. Charly Gaul 1*, Heidemarie Gräter 2 and Thomas Weiser 2

Chronic Migraine: Epidemiology and Disease Burden

doi: /brain/awl202 Brain (2006), 129,

The validity of recognition-based headache diagnoses in adolescents. Data from the Nord-Trøndelag Health Study , Head-HUNT-Youth

its short- and long-term therapeutic efficacy

Harold G. Wolff Lecture Award Winner

Treatment Of Medication. Overuse Headache

Adult & Pediatric Patients. Stanford Health Care, Division Pain Medicine

ANTIMIGRAINE MEDICINES

Update on Diagnosis and Management of Migraines

Specific features of migraine syndrome in children

Coexistence of migraine and idiopathic intracranial hypertension without papilledema

Clinical Learning Days November 10, 2017

ORIGINAL ARTICLE Chronic Daily Headache in Children and Adolescents THE CANADIAN JOURNALOF NEUROLOGICAL SCIENCES 319

Headache Master School Japan-Osaka 2016 II. Management of refractory headaches Case Presentation 2. SUNCT/SUNA: concept, management and prognosis

MEASURE #1: MEDICATION PRESCRIBED FOR ACUTE MIGRAINE ATTACK Headache

Transcription:

Clinical Characteristics of Chronic Daily Headache Patients Visit to University Hospital Jin-Kuk Do, M.D., Hee-Jong Oh, M.D., Dong-Kuck Lee, M.D. Department of Neurology, Taegu Hyosung Catholic University School of Medicine Background : Chronic daily headache(cdh) could be included all of the primary headache disorders with daily or near-daily headache lasting more than 4 hours/day for 15 days/month. Several studies have shown that patients with CDH are difficult to classify using the currently published International Headache Society(IHS) system. Recently, some authors recommended that CDH could be subclassified into transformed migraine(tm), chronic tension-type headache(ctth), new daily persistent headache(ndph) and hemicrania continua(hc). Methods : We analysed 100 patients with CDH who were diagnosed in Taegu-Hyosung Catholic University Hospital from February 1996 to May 1998. To describe clinical features of CDH, we used our CDH protocol. Results : (1) Most of the patients were in their 5th ~ 7th decades, and female was predominantly affected(female to male ratio, 7.3:1). (2) The subclassification of CDH were CTTH in 59 patients, TM in 33 patients, NDPH in 7 patients, and HC in 1 patient. (3) Clinical characteristics of CDH were mostly bilateral location, mild to moderate intensity and dull nature. The mean onset age of CDH was 47.7 years, the onset time of the day was in the afternoon or anytime, the duration was more than 4 hours or 12 hours in 90 patients, and the frequency was near-daily or daily in 80 patients. Common associated symptoms were nausea, dizziness, insomnia, fatigue, photophobia, blurred vision, and scalp tenderness. (4) Daily use of analgesics was reported in 66 patients. CDH was aggravated during premenstrual period in 10 patients. Positive family history was shown in 26 patients. Conclusions : We present this report because knowledge of clinical characteristics and adequate protocol for CDH in clinical practice is necessary. J Kor Neurol Ass 17(1):38~44, 1999 Key Words : Chronic daily headache, Subclassification, Clinical features, Protocol Jin-Kuk Do, M.D. 38 Copyright 1999 by the Korean Neurological Association

Figure 1. Protocol of chronic daily headache(cdh) J Kor Neurol Ass / Volume 17 / January, 1999 39

Table 1. Age of onset in primary headache and CDH Age() Primary headache() CDH() 11-20 16 11 21-30 26 15 31-40 31 22 41-50 18 32 51-60 15 23 61-70 15 12 71-80 11 15 Total 92 100 40 J Kor Neurol Ass / Volume 17 / January, 1999

Table 2. Associated symptoms of CDH (n=100) Symptoms Patients() 46 43 33 28 24 20 20 19 19 15 11 19 16 16 12 11 11 J Kor Neurol Ass / Volume 17 / January, 1999 41

42 J Kor Neurol Ass / Volume 17 / January, 1999

11. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8(suppl 7):1-96. 12. Mathew NT, Reuveni U, Perez F: Transformed or evolutive migraine. Headache 1987;27:102-106. 13. Solomon S, Lipton RB, Newman LC. Evaluation of chronic daily headache - comparison to criteria for chronic tension-type headache. Cephalalgia 1992;12:365-368. 14. Silberstein SD, Lipton RB, Sliwinski M. Classification of daily and near-daily headaches: Field trial of revised IHS criteria. Neurology 1996;47:871-875. 15. Manzoni GC, Granella F, Sandrini G, Antonaci F, Zanferrari C, Nappi G. A computerized record chart for the study of chronic daily headache. Functional Neurol 1993;8:293-300. 16. Silberstein SD, Lipton RB. Chronic daily headache. I n : Goadsby PJ, Silberstein SD, eds. Blue books of practical neurology. vol 17. Headache. Washington: Butterworth- Heinemann, 1997;201-225. 17. 1997;15:847-857. 18. Manzoni GC, Micieli G, Granella F, Martignoni E, Malferrari G, Nappi G. Daily chronic headache: Classification and clinical features: Observation on 250 patients. Cephalalgia 1987;7(suppl 6):169-170. 16. Vanast WJ, Diaz-Mitoma F, Tyrrell DLJ: Hypothesis: Chronic benign daily headache is an immune disorder with a viral trigger. Headache 1987;27:138-142. 19. Solomon S, Lipton RB, Newman LC. Clinical features of chronic daily headache. Headache 1992;32:325-329. 10. Silberstein SD, Lipton RB, Solomon S, Mathew NT. Classification of chronic daily and near daily headaches: Proposed revisions to the IHS criteria. Headache 1994;34: 1-7. 11. Gladstein J, Holden EW. Chronic daily headache in children and adolescents: a 2-year prospective study. H e a d a c h e 1996 ; 35 : 349-51. 12. Srikiatkhachorn A, Phanthumchinda K. Prevalence and clinical features of chronic daily headache in a headache clinic. Headache 1997;37:277-280. 13. Silberstein SD, Silberstein JR. Chronic daily headache: long-term prognosis following inpatient treatment with repetitive IV DHE. Headache 1992;32:439-445. 14. Mathew NT. Chronic refractory headache. N e u r o l o g y 1993;43(suppl 3):S26-S33. 15. Vanast WJ. New daily persistent headache: Definition of a benign syndrome. Headache 1986;26:318-320. 17. Bordini C, Antonaci F, Stovner LJ, Schrader H, Sjaastad O. Hemicrania continua : A clinical review. H e a d a c h e 1991;31:20-26. 18. Newman LC, Lipton RB, Solomon S. Hemicrania continua: 7 new cases and a literature review. Headache 1993; J Kor Neurol Ass / Volume 17 / January, 1999 43

32:267. 19. 1997;15:1-18. 20. 1997;15:615-623. 21. Fusco BM, Colantoni O, Ciacovazzo M. Alteration of central excitation circuits in chronic headache and analgesic misuse. Headache 1997;37:486-491. 22. Mathew NT, Kurman R, Perez F: Drug induced refractory headache - Clinical features and management. H e a d a c h e 1990;30:634-638. 23. Mathew NT. Drug-induced headache. In: Mathew NT, eds. Neurologic Clinics. vol 8. Philadelphia: W. B. Saunders company, 1990;903-912. 24. Mathew NT. Transformed migraine, analgesic rebound, and other chronic daily headaches. In: Mathew NT, eds. Neurologic Clinics. vol 15. Philadelphia: W. B. Saunders company, 1997;167-186. 25. Rasmussen BK. Epidemiology of headache. C e p h a l a l g i a 1995;15:45-68. 26. Kudrow L. Paradoxical effects of frequent analgesic use. In: Critchley M, Friedman A, Corini S, eds. Advances in neurology, vol 33. New York, Raven Press, 1982;335-341. 27. Mathew NT, Stubits E, Nigam MP. Transformation of episodic migraine into daily headache: Analysis of factors. Headache 1982;22:66-68. 28. Saper J. Daily chronic headache. In: Mathew NT, eds. Neurologic Clinics. vol 7. Philadelphia: W. B. Saunders company, 1990;891-901. 29. Sheftell FD. Chronic daily headache. Neurology 1992;42 (suppl 2):32-36. 30. Rapoport AM, Stang P, Gutterman DL, Cady R, Markley H, Weeks R, et al. Analgesic rebound headache in clinical practice: Data from a physician survey. Headache 1 9 9 6 ; 36:14-19. 31. Diener HC, Haab J, Peters C, Ried S, Dichgans J, Pilgrim A. Subcutaneous sumatriptan in the treatment of headache during withdrawal from drug-induced headache. H e a d a c h e 1 9 9 1 ; 3 1 : 2 0 5-2 0 9. 32. Saper JR, Silberstein SD, Lake AE, Winters ME. Doubleblind trial of fluoxetine: Chronic daily headache and migraine. Headache 1994;34:497-502. 33. Bussone G, Sandrini G, Patruno G, Ruiz L, Tassorelli C, Nappi G. Effectiveness of fluoxetine on pain and depression in chronic headache disorders. In: Nappi G, Bono G, Sandrini G, et al, eds. Headache and Depression: Serotonin pathways as a common clue. New York: Raven Press, 1991 ; 2 6 5-2 7 2. 34. Foster CA, Bafaloukos J. Paroxetine in the treatment of chronic daily headache. Headache 1994;34:587-589. 35. Mathew NT, Ali S. Valproate in the treatment of persistent chronic daily headache. An open label study. H e a d a c h e 1 9 9 1 ; 3 1 : 7 1-7 4. 36. Vijayan N, Spillane T. Valproic acid treatment of chronic daily headache. Headache 1995;35:540-543. 44 J Kor Neurol Ass / Volume 17 / January, 1999